| 1 |
35155188 | Case Report: Durable Clinical Response to Third-Line Pyrotinib After Resistance to Trastuzumab in a Gastric Cancer Patient. | 2021 |
1 |
| 2 |
31526900 | Pulsed Reduced Dose Rate for Reirradiation of Recurrent Breast Cancer. | 2020 Mar - Apr |
1 |
| 3 |
28782476 | A Case of Capecitabine-induced Hyperammonemia in a Patient with Colon Cancer. | 2018 |
1 |
| 4 |
26988358 | A comparison of toxicity profiles between the lower and standard dose capecitabine in breast cancer: a systematic review and meta-analysis. | 2016 Apr |
3 |
| 5 |
24908435 | Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer. | 2014 Jul |
1 |
| 6 |
24923572 | Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: a retrospective analysis from a medical center. | 2014 May-Jun |
1 |
| 7 |
23647753 | Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer. | 2013 May |
1 |
| 8 |
23876062 | A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial. | 2013 Jul 22 |
2 |
| 9 |
20460474 | Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome. | 2010 May 15 |
1 |
| 10 |
20485287 | Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment. | 2010 Jun 8 |
1 |
| 11 |
18670776 | A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma. | 2009 Apr |
1 |
| 12 |
18414469 | A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours. | 2008 Apr 22 |
3 |
| 13 |
17530484 | A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine. | 2007 Apr-May |
1 |
| 14 |
17762433 | A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer. | 2007 Aug |
1 |
| 15 |
15894361 | Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer. | 2005 Jun |
2 |
| 16 |
12763217 | An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer. | 2003 Jun |
4 |
| 17 |
11919232 | Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. | 2002 Apr 1 |
1 |
| 18 |
11977645 | [Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer]. | 2002 Jan |
1 |
| 19 |
12351595 | Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. | 2002 Oct 1 |
3 |